Related Experiment Video
Updated: Jan 7, 2026

03:10
Author Spotlight: Development and Evaluation of a Compound Acne Rodent Model Using C. acnes and Oleic Acid
Published on: November 1, 2024
3.6K
Skin-Derived Precursors-Derived Exosomes Alleviated Acne Inflammation via TLR2/MyD88/NF-κB Signaling Pathway:
Yiming Li1, Shiyi Li2, Manlin Guo3
1Department of Dermatology, Institute of Traditional Chinese Medicine of Sichuan Academy of Chinese Medicine Sciences, Chengdu, Sichuan, China.
Summary
Mouse skin-derived precursor exosomes (mSKPs-exo) reduce acne inflammation by modulating the TLR2/MyD88/NF-κB pathway. These exosomes show potential for treating inflammatory skin conditions like acne.
Area of Science:
- Exosome biology
- Immunology
- Dermatology
Background:
- Skin-derived precursors (SKPs) are poorly immunogenic and modulate immune responses.
- Previous studies suggested mouse SKPs-derived exosomes (mSKPs-exo) possess immunomodulatory functions.
- Acne vulgaris is an inflammatory skin condition often involving Cutibacterium acnes (C. acnes).
Purpose of the Study:
- To investigate the immunomodulatory and anti-inflammatory effects of mSKPs-exo on acne inflammation.
- To explore the underlying molecular mechanisms involving the TLR2/MyD88/NF-κB pathway.
- To evaluate the therapeutic potential of mSKPs-exo for acne treatment.
Main Methods:
- Isolation and characterization of mSKPs-exo via ultracentrifugation.
- In vitro studies using C. acnes-challenged RAW264.7 macrophages.
- In vivo studies using a Sprague Dawley (SD) rat auricular acne model.
- Analysis of inflammatory markers, pathway-related genes, and proteins using RT-PCR, Western blot, and immunohistochemistry.
Main Results:
- mSKPs-exo reduced nitric oxide, TNF-α, and IL-6 in vitro.
- mSKPs-exo ameliorated NF-κB p65 nuclear translocation and key inflammatory markers in macrophages.
- mSKPs-exo regulated TLR2/MyD88/NF-κB pathway components in vitro and in vivo.
- Topical mSKPs-exo application alleviated auricular inflammation in rats, comparable to adapalene.
Conclusions:
- mSKPs-exo exhibit significant anti-inflammatory effects relevant to acne treatment.
- The anti-inflammatory action is mediated through the regulation of the TLR2/MyD88/NF-κB signaling pathway.
- mSKPs-exo represent a promising therapeutic agent for inflammatory skin conditions and acne.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
3.2K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.2K
The Extrinsic Apoptotic Pathway
8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K

